Safety and immunogenicity of a first dose of SARS‐CoV‐2 mRNA vaccine in allogeneic hematopoietic stem‐cells recipients

This was a monocentric prospective study testing the efficacy and safety of a first injection of BNT162b2 (Pfizer‐BioNTech) in 112 Allo‐HSCT patients. Antibody response to SARS‐CoV‐2 spike protein receptor‐binding domain was tested at the time of the second injection (Roche Elecsys). The study also...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EJHaem
Main Authors: Chevallier, Patrice, Coste‐Burel, Marianne, Le Bourgeois, Amandine, Peterlin, Pierre, Garnier, Alice, Béné, Marie C., Imbert, Berthe‐Marie, Drumel, Thomas, Le Gouill, Steven, Moreau, Philippe, Mahe, Beatrice, Dubruille, Viviane, Blin, Nicolas, Lok, Anne, Touzeau, Cyrille, Gastinne, Thomas, Jullien, Maxime, Vanthygem, Sophie, Guillaume, Thierry
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Short Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8242867/
https://ncbi.nlm.nih.gov/pubmed/34226903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jha2.242
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados